The largest database of trusted experimental protocols

Hrp conjugated goat anti human igg secondary antibody

Manufactured by Thermo Fisher Scientific

The HRP-conjugated goat anti-human IgG secondary antibody is a laboratory reagent used for the detection of human immunoglobulin G (IgG) in various immunoassay applications. The antibody is conjugated with horseradish peroxidase (HRP), an enzyme that can be used to catalyze a colorimetric or chemiluminescent reaction, enabling the visualization and quantification of target IgG molecules.

Automatically generated - may contain errors

4 protocols using hrp conjugated goat anti human igg secondary antibody

1

Serum Antibody Titer Assay for Clade C gp140

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum binding antibody titers against clade C gp140 trimer were determined by endpoint ELISAs as previously described [11 (link), 12 (link)]. Briefly, 96-well Maxisorp ELISA plates (Thermo Fisher Scientific), coated over-night with 100 μl/well of 1 μg/ml clade C gp140, were blocked for 2.5 hours with PBS/Casein (Pierce). Guinea pig sera were then added in serial dilutions and incubated for 1 hour at room temperature. The plates were washed three times with PBS containing 0.05% Tween 20 (Sigma) and incubated for 1 hour with a 1/2,000 dilution of a horseradish peroxidase (HRP)-conjugated goat anti-guinea pig secondary antibody (Jackson ImmunoResearch Laboratories) or HRP-conjugated goat anti-human IgG secondary antibody (Fisher Scientific) for NHP assays. The plates were washed three times and developed with SureBlue tetramethylbenzidine (TMB) microwell peroxidase (KPL Research Products), stopped by the addition of stop solution (KPL Research products), and analyzed at 450 nm/550 nm with a Spectramax Plus ELISA plate reader (Molecular Devices) using Softmax Pro 4.7.1 software. ELISA endpoint titers were defined as the highest reciprocal serum dilution that yielded an absorbance >2-fold over background values.
+ Open protocol
+ Expand
2

ELISA for Antibody Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
PGDM1400 and CAP256-VRC26.25-LS antibody concentration in serum was determined by ELISA as described (41 (link)) using the BG505 SOSIP trimer or the novel CNE58-strandC-CAP256.SU SOSIP trimer, respectively. Briefly, microtiter plates were coated with 1 μg/mL SOSIP trimer and incubated overnight at 4°C. The plates were washed with PBS/0.05% Tween-20 and blocked with PBS/Casein (Pierce). After blocking, serial dilution of serum samples were added to the plate and incubated for 2 h at 37 °C. Binding was detected with a horseradish peroxidase (HRP)-conjugated goat anti-human IgG secondary antibody (Fisher Scientific) and visualized with SureBlue tetramethylbenzidine (TMB) microwell peroxidase (KPL Research Products).
+ Open protocol
+ Expand
3

SARS-CoV-2 Antibody Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, Maxisorp plates were coated with a capture antibody (Fitzgerald, PreS2, Cat. 10-H08A) at 5 µg/mL overnight. Plates were blocked with 4% skim milk in PBS (SM-PBS) buffer at room temperature for 2 h and then incubated with the virus at 4 °C overnight. Plates were then incubated with antibodies at room temperature (various concentrations) diluted in blocking buffer for 1 h. Each well was then incubated with an HRP-conjugated goat-anti-human IgG secondary antibody (Thermo Fisher, cat. #31413, diluted 3000×) for 1 h, followed by incubation with TMB substrate (Thermo Fisher, cat. #34028) for color development before H2SO4 addition to stop color development. OD450 was recorded. Plates were washed four times with PBS between all incubation steps. Antibody-coated wells with no virus added were included as negative controls.
+ Open protocol
+ Expand
4

Screening Recombinant HLA Peptide Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, maxisorp plates were coated with streptavidin, blocked with 3% bovine serum albumin (BSA) in PBST buffer at room temperature and then incubated with biotinylated refolded recombinant peptide-HLA complexes at 4 °C overnight. Plates were then incubated with 1 μg mL−1 anti-HLA antibodies diluted in blocking buffer for 2 h. After that, each well was incubated with HRP-conjugated goat-anti-human IgG secondary antibody (Thermo Fisher Scientific, cat. #31413, diluted 10,000×) for 45 min, followed by incubation with TMB substrate for color development. Streptavidin coated wells with no HLA were included as negative controls. Plates were washed four times in PBST between all incubation steps. H2SO4 was added to stop color development. OD450 was recorded.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!